These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 30017593)

  • 1. Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature.
    Ahmad AS; Tahir RA; Mitsias PD
    J Clin Neurosci; 2018 Oct; 56():177-179. PubMed ID: 30017593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reply to 'Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature'.
    Wegner F; Müller-Ladner U; Meier FM
    J Clin Neurosci; 2019 May; 63():281. PubMed ID: 30732990
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute Thyrotoxicosis of Graves Disease Associated with Moyamoya Vasculopathy and Stroke in Latin American Women: A Case Series and Review of the Literature.
    Shah NH; Khandelwal P; Gordon-Perue G; Shah AH; Barbarite E; Ortiz G; Forteza AM
    World Neurosurg; 2016 Aug; 92():95-107. PubMed ID: 27163552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moyamoya syndrome with antiphospholipid antibodies: a case report and literature review.
    Wang Z; Fu Z; Wang J; Cui H; Zhang Z; Zhang B
    Lupus; 2014 Oct; 23(11):1204-6. PubMed ID: 24939972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anti-U1RNP- and anti-Scl-70-antibodies with neurological manifestations in systemic sclerosis (scleroderma).
    Hietarinta M; Lassila O; Hietaharju A
    Scand J Rheumatol; 1994; 23(2):64-7. PubMed ID: 8165439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accelerated intracranial occlusive disease, oral contraceptives, and cigarette use.
    Levine SR; Fagan SC; Pessin MS; Silbergleit R; Floberg J; Selwa JF; Vogel CM; Welch KM
    Neurology; 1991 Dec; 41(12):1893-901. PubMed ID: 1745344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive stenosis and radiological findings of vasculitis over the entire internal carotid artery in moyamoya vasculopathy associated with graves' disease: a case report and review of the literature.
    Ito H; Yokoi S; Yokoyama K; Asai T; Uda K; Araki Y; Takasu S; Kobayashi R; Okada H; Okuda S
    BMC Neurol; 2019 Mar; 19(1):34. PubMed ID: 30825882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angioplasty for acute stroke with pediatric moyamoya syndrome.
    El-Hakam LM; Volpi J; Mawad M; Clark G
    J Child Neurol; 2010 Oct; 25(10):1278-83. PubMed ID: 20505156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moyamoya-like vasculopathy (moyamoya syndrome) in children.
    Horn P; Pfister S; Bueltmann E; Vajkoczy P; Schmiedek P
    Childs Nerv Syst; 2004 Jun; 20(6):382-91. PubMed ID: 15127215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Good outcome of interstitial lung disease in patients with scleroderma associated to anti-PM/Scl antibody.
    Guillen-Del Castillo A; Pilar Simeón-Aznar C; Fonollosa-Pla V; Alonso-Vila S; Reverte-Vinaixa MM; Muñoz X; Pallisa E; Selva-O'allaghan A; Fernández-Codina A; Vilardell-Tarrés M
    Semin Arthritis Rheum; 2014 Dec; 44(3):331-7. PubMed ID: 25110305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Autoimmune antibody in moyamoya disease].
    Wanifuchi H; Kagawa M; Takeshita M; Izawa M; Maruyama S; Kitamura K
    No Shinkei Geka; 1986 Jan; 14(1):31-5. PubMed ID: 3485262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood moyamoya disease and moyamoya syndrome: a pictorial review.
    Currie S; Raghavan A; Batty R; Connolly DJ; Griffiths PD
    Pediatr Neurol; 2011 Jun; 44(6):401-13. PubMed ID: 21555050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Moyamoya vasculopathy - Patient demographics and characteristics in the Finnish population.
    Saarela M; Mustanoja S; Pekkola J; Tyni T; Hernesniemi J; Kivipelto L; Tatlisumak T
    Int J Stroke; 2017 Jan; 12(1):90-95. PubMed ID: 27625049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unusual association between lysinuric protein intolerance and moyamoya vasculopathy.
    Ghilain V; Wiame E; Fomekong E; Vincent MF; Dumitriu D; Nassogne MC
    Eur J Paediatr Neurol; 2016 Sep; 20(5):777-81. PubMed ID: 27321952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid Autoantibodies and the Clinical Presentation of Moyamoya Disease: A Prospective Study.
    Lanterna LA; Galliani S; Zangari R; Conti L; Brembilla C; Gritti P; Colleoni ML; Bernucci C
    J Stroke Cerebrovasc Dis; 2018 May; 27(5):1194-1199. PubMed ID: 29305275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presumed perinatal stroke in a child with Down syndrome and moyamoya disease.
    Pysden K; Fallon P; Moorthy B; Ganesan V
    Dev Med Child Neurol; 2010 Feb; 52(2):212-4. PubMed ID: 19583743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral vasculopathy associated with collateralization resembling moya moya phenomenon and with anti-Ro/SS-A and anti-La/SS-B antibodies.
    Provost TT; Moses H; Morris EL; Altman J; Harley JB; Alexander E; Reichlin M
    Arthritis Rheum; 1991 Aug; 34(8):1052-5. PubMed ID: 1859480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal profile of de novo development of moyamoya vasculopathy in an adult: case report.
    Shimoda Y; Fujimura M; Inoue T; Shimizu H; Tominaga T
    Neurol Med Chir (Tokyo); 2012; 52(5):339-42. PubMed ID: 22688072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of anti-centromere and anti-Scl 70 antibodies in scleroderma. Report of two cases.
    Ruffatti A; Calligaro A; Ferri C; Bombardieri S; Gambari PF; Todesco S
    J Clin Lab Immunol; 1985 Apr; 16(4):227-9. PubMed ID: 3874966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient Ischemic Attack in Pediatric Patients With Moyamoya Disease: Clinical Features, Natural History, and Predictors of Stroke.
    Zhao M; Zhang D; Wang S; Zhang Y; Wang R; Zhao J
    Pediatr Neurol; 2017 Oct; 75():48-54. PubMed ID: 28778481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.